CS logo
small CS logo
John D. Archbold Memorial Hospital

Thomasville, Georgia, United States
Hospital department in Thomasville, Georgia
915 Gordon Ave, Thomasville, GA 31792

About John D. Archbold Memorial Hospital


"Archbold Medical Center is a four-hospital, three nursing-home health system with 540 patient beds. We employ more than 2,500 people and boast an outstanding medical staff of nearly 200 qualified physician specialists. Our flagship hospital, John D. Archbold Memorial Hospital, is a 264-bed hospital located in Thomasville, Georgia. Our system hospitals, also in Georgia, are Brooks County Hospital in Quitman, Grady General Hospital in Cairo, and Mitchell County Hospital in Camilla."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
BeiGene
1
Celcuity, Inc.
1
Gilead Sciences
1
Janssen Research & Development, LLC
1
Novartis Pharmaceuticals
1
Pfizer
1
Total Rows: 6

Clinical Trials at John D. Archbold Memorial Hospital


During the past decade, John D. Archbold Memorial Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110022000011Started TrialsCompleted Trails2020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis.
2011-06-30
2014-04-30
Completed
43
A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
2014-09-30
2018-04-19
Completed
394
Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)
Approved for marketing
Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants
2020-07-06
2021-02-01
Completed
63
Roll-over Study to Allow Continued Access to Ribociclib
2022-07-07
2028-02-16
Recruiting
137
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
2022-09-30
2026-09-30
Recruiting
701

Rows per page:

1–6 of 6

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "John D. Archbold Memorial Hospital" #1 sponsor was "BeiGene" with 1 trials, followed by "Celcuity, Inc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsBeiGene: 1BeiGene: 1Celcuity, Inc.: 1Celcuity, Inc.: 1Gilead Sciences: 1Gilead Sciences: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1Novartis Pharmaceuticals: 1Novartis Pharmaceuticals: 1Pfizer: 1Pfizer: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at John D. Archbold Memorial Hospital


According to Clinical.Site data, the most researched conditions in "John D. Archbold Memorial Hospital" are "Breast Cancer" (1 trials), "COVID-19" (1 trials), "COVID-19 Pulmonary Complications" (1 trials), "Follicular Lymphoma" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "John D. Archbold Memorial Hospital" in a lesser frequency.

Clinical Trials Intervention Types at John D. Archbold Memorial Hospital


Most popular intervention types in "John D. Archbold Memorial Hospital" are "Drug" (5 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Fulvestrant" (2 trials), "Alpelisib" (1 trials), "Anastrozole" (1 trials), "CV-18C3" (1 trials) and "Gedatolisib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at John D. Archbold Memorial Hospital


The vast majority of trials in "John D. Archbold Memorial Hospital" are 6 trials for "All" genders.

Clinical Trials Status at John D. Archbold Memorial Hospital


Currently, there are NaN active trials in "John D. Archbold Memorial Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in John D. Archbold Memorial Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in John D. Archbold Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 2Phase 2: 2Phase 3: 2Phase 3: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Recruiting: 2Recruiting: 2Approved for marketing: 1Approved for marketing: 1